Sfoglia per AUTORE
BURGIO V
Collezione AO Cuneo

  

Items : 2

Impact of gender on the safety profile of chemotherapy plus bevacizumab in mCRC: A pooled analysis of TRIBE and TRIBE2 studies in Journal of Clinical Oncology

2019
AO Cuneo
AOU Città della Salute di Torino

Zucchelli G; Moretto R; Schirripa M; Intini R; Rossini D; Santini D; Pizzo C; Antoniotti C; Borelli B; Marmorino F; Urbano F; Burgio V; Libertini M; Prisciandaro M; Buonadonna A; Bustreo S; Allegrini G; Ricci V; Cremolini C; Falcone A;

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer. in ESMO open / ESMO Open. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403. eCollection 2018.

2018
AO Cuneo

Falcone A; Boni L; Cremolini C; Delliponti L; Vitello S; Antonuzzo L; Martinelli E; Vannini F; Marsico VA; Colombo C; Granetto C; Leone F; Passardi A; Boccaccino A; Pella N; Di Battista M; Martignetti A; Zaniboni A; Zucchelli G; Salvatore L; Rossini D; Marmorino F; Burgio V; Masi G; Pietrantonio F; Bonetti A; Antoniotti C; Lonardi S; Borelli B; et alii...